Original title: Hong Kong and US IPO Weekly Report | Dingdang Health Passed Hong Kong Stock Exchange Hearing and Dajian Yuncang B2B Trading Platform Listed in the United States
Last week (Aug 18 – Aug 21 2022), 2 companies inListed in Hong Kong2Chinese conceptual actionsto existUS stock market。
In the period, 1 company passed the Hong Kong Stock Exchange hearing and 2 companies entered the IPO.
In terms of form submissions, a company submitted a form to the Hong Kong Stock Exchange last weekIPO listing, 1 Chinese concept stock submitted a form to the SEC. Here is the full list:
one,List: Huide, the third SPAC company in the Hong Kong stock market, acquired -Z and officially landed in the Hong Kong stock market
Last week, a total of 2 companies went public on the Hong Kong stock market, most notably Huide Acquisition-Z and Shuangcaizhuang.
Acquisition of Huide-Z listed in Hong Kong
Huide Acquisition-Z IPO is expected to issue 100 million shares,issue priceThat’s HK $ 10 per share and 115,000 shares per lot.
The founders of the company are Chen Delin, Zeng Jingxuan and Juyi. All of the promoter’s shares will be held by Hong Kong Huide Limited, which is 51% owned by Extra Shine (wholly owned by Chen Delin), 32% by Pride Vision (wholly owned by Zeng Jingxuan) and 17% by Juyi.
The company intends to focus on sustainability eCorporate governanceCompetitive advantage in terms of, and has operations or should have operations in the Greater China regionFinancial servicesor technology companies.
2. Hong Kong stock hearing and prospectus listing: Dingdang Health passed the Hong Kong Stock Exchange hearing
Last week, a total of 1 company passed the Hong Kong Stock Exchange hearing and 2 companies initiated the IPO, including China CDFG closed the IPO.
Dingdang Health, a digital home health provider, passed the HKEx hearing
According to the Frost & Sullivan report, in terms of revenue in 2021, the Company is a leading service provider in the digital retail pharmacy industry in China, ranking third in the industry with a 1.0% market share.
Dingdang Health’s revenue comes mainly from the pharmaceutical and healthcare and other sectors. Pharmaceutical and healthcare revenue includes revenue generated from direct online sales, corporate distribution and offline retail, which together accounted for more than 95% of our revenue during the Track Record Period. Others mainly include marketing services, marketing services and other services.
From 2018 to 2021 and the first quarter of 2022, the company’s revenue was 585 million yuan, 1.276 billion yuan, 2.229 billion yuan, 3.679 billion yuan and 987 million yuan respectively; in the same period, the total loss and total expense during the year were 103 million yuan, 274 million yuan, 920 million yuan, 1.6 billion yuan and 404 million yuan.
China CDFG closes IPO, imminent listing
China CDFG this timeThe final issue price for foreign shares (H shares) is HK $ 158 per share and is expected to be listed on August 25, 2022.
According to Frost & Sullivan, secondAccording to the calculations, the global ranking of the company will be ranked first in the world in 2020 and 2021.
For the years ended December 31, 2019, 2020, and 2021, the company’s revenues were RMB 48.013 billion, RMB 52.598 billion and RMB 67.676 billion respectively, while the company’s revenues wereThey were respectively 5.471 billion yuan, 7.109 billion yuan and 12.441 billion yuan. From 2019 to 2021, the company’s revenues will grow at a CAGR of 18.7%, while the company’s net income will grow at a CAGR of 50.8%.
three,US stock marketListing: Dajian Yuncang is listed in the United States and JD.com is a shareholder
Last week, a total of 2 Chinese concept stocks went public on the US stock market, most notably Dajian Yuncang and New Materials for the Stone Tram.
Dajian Yuncang, a B2B trading platform, has landed on Nasdaq
Dajian Yuncang’s initial price was $ 12.25 and 2.94 million Class A common shares were issued. On the first day of listing, Dajian Yuncang rose more than 68% intraday. At the end of the day, Dajian Yuncang reported $ 15.69, up 28.08%, with a total market value of $ 624 million.
Dajian Cloud Warehouse is a B2B trading platform engaged in the export of bulky goods. Dajian Cloud Warehouse focuses on international wholesale merchandise trade, transforms the traditional foreign trade sector through digital commerce, and provides comprehensive online or offline cross-border transaction and delivery services for global wholesale goods. The company launched GigaCloud Marketplace, a large-scale e-commerce platform under its Hong Kong branch in 2019.
Financially, the company’s total revenue for 2019-2021 and the three months ending March 31, 2021 and March 31, 2022 was $ 122.3 million, $ 275.5 million, $ 414, respectively. 2 million, $ 94.5 million and $ 94.5 million, $ 112.4 million; income was $ 2.9 million, $ 37.5 million, $ 29.3 million, $ 8 million and $ 4.7 million, respectively.
In the shareholder structure before the listing, Jingdong accounted for 11.3% and the Red Star 7.9%.
4. List of US Share Listing Requests: Hong Kong Information Global Engine Group submits a prospectus
Last week, a Chinese concept stock filed a prospectus with the SEC. Global Engine Group intends to issue 17 million common shares under the name “GLE”.
The company is an integrated solutions provider that drives business results and innovation through the use of information and communication technology (“ICT”) solutions.
In the fiscal year ending June 30, 2021, the company’s turnover was HK $ 25.6 million, compared to HK $ 10 million in the same period last year; in the same period, net profit was HK $ 7 million, compared to HK $ 3.1 million in the same period last year.
5. Outlook for new stocks this week
This week (22 Aug-28 Aug) 2 companies are expected to joinHong Kong IPOListed, no Chinese titles are listedIPO of US shareslisted.Back to Sohu, see more
–
Publisher:
–
Disclaimer: The views of this article represent only the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.
